Important Announcements

ACL Laboratories continuously strives to provide the best laboratory services possible. Our Test Bulletins and Important Announcements include information regarding new test offerings, changes in test procedures, reference range changes, or modifications in specimen collection protocol and/or new specimen collection devices.

nov. 06, 2018

November 2018 Test Bulletin

ACL Laboratories Revises General Requisition -- CHANGE: Urine Chemistry Storage, Stability, and Transport -- ACL Laboratories Adds Toxin EIA Testing to C. difficile Testing Algorithm -- NT proBNP, Frequently Asked Questions -- Digoxin Specimen Collection/Draw Time -- ACL Laboratories Offers New Quantitative Pain Management Drug Testing Panel Read more

oct. 03, 2018

October 2018 Test Bulletin

Save time, money, resources, and precious blood…by NOT collecting extra specimens “just in case” -- Addendum to Previously Published September 2018 Test Bulletin Article: Activated Partial Thromboplastin Time (Test Order Code APTT) Reference Range Changes -- ACL Implements New Methodology for HIV-1 Viral Load Testing -- ACL Implements New Methodology for HCV ... Read more

aug. 28, 2018

September 2018 Test Bulletin

ALA Dehydratase, Whole Blood (Test Order Code ALADWB) -- Activated Partial Thromboplastin Time (Test Order Code APTT) Reference Range Changes -- Cyanide, Blood (Test Order Code CYANID) Read more

jul. 30, 2018

August 2018 Test Bulletin

Cyclospora Outbreak -- ACL Announces New Test NT proBNP (Test Order Code NTPBNP) -- Prenatal Maternal Serum Aneuploidy Screening Updates -- ACL Announces New Test, Testosterone Free and Total, Bioavailable & SHBG, Male (Test Order Code TSTFPB) -- Potential Sulfasalazine Interference with Routine Chemistry Tests -- ACL Laboratories Discontinues Campylobacter Antigen Test (Test Order Code CAMPAG ... Read more

jul. 09, 2018

July 2018 Test Bulletin

Quantiferon-TB Gold Plus, Blood (Test Order Code QUANTP) Test Update -- ACL Implements New Policy for Handling Specimens with Non-ACL Requisitions -- Specimen Identification and Labeling -- New Medicare Cards: Medicare Beneficiary ID (MBI) Final Reminders -- Change in Reporting for Clostridium difficile Toxin, PCR; C. difficile by DNA Amplification (Bay Area Medical Center ... Read more